PATENT CLAIM ANALYSIS

Application Number: 15893772
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "450000"]

Abstract:
The present invention relates to RNA containing compositions for use in the treatment or prophylaxis of tumor and/or cancer diseases, to a pharmaceutical composition, to a kit and to uses of the RNA containing compositions for the treatment or prophylaxis of tumor and/or cancer diseases.

Claim (Index 6):
The method of  claim 5 , wherein the checkpoint modulator therapy is selected from the group consisting of a PD-1 inhibitor, a PD-L1 inhibitor, a CTLA-4 inhibitor, a LAG3 inhibitor, a TIM3 inhibitor, an OX-40 stimulator, a 4-1BB stimulator, a CD40L stimulator, a CD28 stimulator, and a GITR stimulator.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 88.0
- Lexical Diversity: 1.71429
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15136295', '15890413', '15890736', '14769720', '12994407']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7916972594969591
- 35 USC 102 Novelty (BERT): 0.6125903852369589
- Combined Prediction Score: 0.7737865720709591
- Mean Citation Score: 418.937378
- Max Citation Score: 730.5600599999997
- Similarity Product: 471.71503778770193

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test